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ferential extent of RF injury between one and two cycle treatment groups.
CONCLUSIONS The Terumo Iberis RDN system was demonstrated
to be safe following single or double-cycle RF ablation. NE decrease
following RDN was demonstrated at 7, 30, and 90 days compared to
naïve controls, suggesting efﬁcient nerve ablation with the device as
intended for human use.
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BACKGROUND The blood pressure (BP) response to renal denervation
(RDN) is highly variable. In addition, the changes in renal artery (RA)
dimensions induced by RDN have rarely been quantiﬁed and never
been related to BP changes.
METHODS We investigated RAs of 16 patients (7 females, 11 diabetics,
mean age 62.6 years) pre and post RDN (Symplicity Flex in 9 pts,
Symplicity Spyral in 7 pts; both Medtronic Inc) with intravascular ul-
trasound (Atlantis pro, Boston Scientiﬁc iLab). IVUS images were
analyzed with QCU-CMS research software (LUMC) yielding global
measures of RA size (RA vessel volume VV, lumen volume LV, wall
volume WV), and measures of most pronounced focal changes (min-
imum and maximum vessel area VA, lumen area LA and wall burden
WB) - Figure. Patients were followed with ofﬁce and 24 hour blood
pressure monitoring at month 1, 3, 6, and 12.
RESULTS Pre RDN, 24 hour BP was 153/88 mm Hg, mean number of
ablation points was 11.3 (SD 3.4). After 1, 3, 6, and 12 months, 24 hour
BP decreased by 12/7, 6/4, 17/9, and 21/11 mm Hg, respectively. RDN
induced a non-signiﬁcant decrease in RA vessel volume of 5.6 (SD 9.8)
%, a signiﬁcant decrease of RA lumen volume of 8.8 (SD 10.7)%, and a
non-signiﬁcant increase of RA wall volume of 6.1 (SD 10.9) %. Max and
min LA decreased signiﬁcantly by 7.3 (SD 9.4) and 10.5 (14.3) %,
respectively, as did min VA by 7.1 (12.5) %. Max vessel area and min
and max wall burden did not change signiﬁcantly. Women had smaller
RAs, which was related to their lower body height. Changes in RA size
were similar between men and women, as were changes in blood
pressure. ABPM-based BP change at 1 (SBP, DBP), 3 (SBP, DBP), 6 (DBP)
and 12 (DBP) months was signiﬁcantly and directly related to changes
in min LA and min VA (correlation coeffﬁcients 0.63-0.80, p-values
0.002-0.02). At 1 year, decrease in SBP was related to increase in wall
volume post RDN (r¼ -0.88, p¼0.004). Patients with a decrease in
minimal VA post RDN above the median had a signiﬁcantly better BP
response at 1 and 3 months. Patients with an increase in WV post RDN
had a signiﬁcantly better SBP response at 6 and 12 months.CONCLUSIONS RDN leads to effects on RA dimensions (decrease in
vessel and lumen size, increase in wall thickness), which can be
quantiﬁed by IVUS. A higher degree of changes may be associated
with a better BP response to the procedure.
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BACKGROUND Renal artery RF ablation is under investigation for the
treatment of hypertension. Recent research suggests lesion anatomic
placement may impact efﬁcacy of RF catheter renal ablation. Due to the
closer proximity of renal sympathetic nerves in the distal vessel segments,
it has been suggested that treatment of the renal artery branches might
help to reduce variability in efﬁcacy. However, it is unclear whether
focused distal treatment of the main renal artery is as effective as branchþ
main renal artery treatment. This study was initiated to investigate the
overall performance of two RF renal nerve ablation systems as well as
ablation anatomic location within the main renal and or bifurcations.
METHODS Sixteen swine were treated unilaterally with either 8 le-
sions in the branch renal arteries (BA) or 8 in the branch þ 4 in the
main renal artery (MA) with the Medtronic Spyral(TM) catheter (SP) or
in the MA alone with the St. Jude Medical EnligHTN(TM) catheter (EN)
in one of four arms: 1) SP8 - 8 BA lesions, 2) SP12 - 8 BA þ 4 MA lesions,
3) EN8 - 8 MA lesions, or 4) EN12 - 12 MA lesions. Treatment followed
manufacturers’ instructions for use & were performed by one proce-
duralist. All lesions in the MA were placed as distal as possible without
overlapping treatment sites. Animals were euthanized at 14 days with
each serving as its own control for norepinephrine (NE) analysis.
RESULTS A total of 162 lesions (EN n¼80 & SP n¼82) were created. All re-
sults are given asmean & StDev unless stated otherwise. Each arm showed
statistical signiﬁcant changes in NE (ng/g) between treated kidneys vs.
untreated contralateral control (C): EN8 125.0159.0 vs. EN8-C 461.284.1
(P¼0.010), EN12 22.9 14.7 vs. EN12-C 492.8 62.9 (P<0.001), SP8 106.1
78.4 vs. SP8-C 438.5 66.4 (P<0.001), SP12 72.5 79.8 vs. SP12-C 411.155
96.7 (P¼0.002). Therewereno statistically signiﬁcant differences in tissue
NE % reductions across each arm based on catheter, anatomic location, &
number of lesions: EN8 –74 34%, EN12 –95 3%, SP8 – 76 16%, SP12 –82
17% (P¼0.494). Nerve count based on anatomic location & lesion pathol-
ogy results will be presented.CONCLUSIONS There was no difference observed between the %
reduction in tissue NE levels comparing main renal artery distal
treatment with the EnligHTN catheter & branch þ main renal artery
treatment with the Spyral catheter.
